293 related articles for article (PubMed ID: 25482724)
1. Mutations of epigenetic regulatory genes are common in thymic carcinomas.
Wang Y; Thomas A; Lau C; Rajan A; Zhu Y; Killian JK; Petrini I; Pham T; Morrow B; Zhong X; Meltzer PS; Giaccone G
Sci Rep; 2014 Dec; 4():7336. PubMed ID: 25482724
[TBL] [Abstract][Full Text] [Related]
2. Thymic Epithelial Tumors phenotype relies on miR-145-5p epigenetic regulation.
Bellissimo T; Ganci F; Gallo E; Sacconi A; Tito C; De Angelis L; Pulito C; Masciarelli S; Diso D; Anile M; Petrozza V; Giangaspero F; Pescarmona E; Facciolo F; Venuta F; Marino M; Blandino G; Fazi F
Mol Cancer; 2017 May; 16(1):88. PubMed ID: 28486946
[TBL] [Abstract][Full Text] [Related]
3. Methylation and expression profiles of MGMT gene in thymic epithelial tumors.
Mokhtar M; Kondo K; Namura T; Ali AH; Fujita Y; Takai C; Takizawa H; Nakagawa Y; Toba H; Kajiura K; Yoshida M; Kawakami G; Sakiyama S; Tangoku A
Lung Cancer; 2014 Feb; 83(2):279-87. PubMed ID: 24388682
[TBL] [Abstract][Full Text] [Related]
4. GTF2I mutation frequently occurs in more indolent thymic epithelial tumors and predicts better prognosis.
Feng Y; Lei Y; Wu X; Huang Y; Rao H; Zhang Y; Wang F
Lung Cancer; 2017 Aug; 110():48-52. PubMed ID: 28676218
[TBL] [Abstract][Full Text] [Related]
5. Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs).
Tiseo M; Damato A; Longo L; Barbieri F; Bertolini F; Stefani A; Migaldi M; Gnetti L; Camisa R; Bordi P; Buti S; Rossi G
Lung Cancer; 2017 Feb; 104():24-30. PubMed ID: 28212996
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetic characteristics of thymic epithelial tumors with distinct histological subtypes.
Yang J; Zhang B; Guan W; Fan Z; Pu X; Zhao L; Jiang W; Cai W; Quan X; Miao S; Nie L; He L
Cancer Med; 2023 May; 12(9):10575-10586. PubMed ID: 36916520
[TBL] [Abstract][Full Text] [Related]
7. The Molecular Landscape of Thymic Epithelial Tumors: A Comprehensive Review.
Elm L; Levidou G
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338833
[TBL] [Abstract][Full Text] [Related]
8. Genomic characterization of thymic epithelial tumors reveals critical genes underlying tumorigenesis and poor prognosis.
Tan S; Chen J; Wang Z; Zhao X; Sun Y; Zhu Y; Gong Z; Zhang D
Clin Genet; 2023 May; 103(5):529-539. PubMed ID: 36541162
[TBL] [Abstract][Full Text] [Related]
9. Discovery and validation of DNA methylation markers for overall survival prognosis in patients with thymic epithelial tumors.
Li S; Yuan Y; Xiao H; Dai J; Ye Y; Zhang Q; Zhang Z; Jiang Y; Luo J; Hu J; Chen C; Wang G
Clin Epigenetics; 2019 Mar; 11(1):38. PubMed ID: 30832724
[TBL] [Abstract][Full Text] [Related]
10. Aberrant DNA methylation in thymic epithelial tumors.
Chen C; Yin B; Wei Q; Li D; Hu J; Yu F; Lu Q
Cancer Invest; 2009 Jun; 27(5):582-91. PubMed ID: 19340654
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation of GHSR, GNG4, HOXD9 and SALL3 is a common epigenetic alteration in thymic carcinoma.
Kishibuchi R; Kondo K; Soejima S; Tsuboi M; Kajiura K; Kawakami Y; Kawakita N; Sawada T; Toba H; Yoshida M; Takizawa H; Tangoku A
Int J Oncol; 2020 Jan; 56(1):315-326. PubMed ID: 31746370
[TBL] [Abstract][Full Text] [Related]
12. Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets.
Enkner F; Pichlhöfer B; Zaharie AT; Krunic M; Holper TM; Janik S; Moser B; Schlangen K; Neudert B; Walter K; Migschitz B; Müllauer L
Pathol Oncol Res; 2017 Jul; 23(3):551-564. PubMed ID: 27844328
[TBL] [Abstract][Full Text] [Related]
13. Genomic Analysis of Thymic Epithelial Tumors Identifies Novel Subtypes Associated with Distinct Clinical Features.
Lee HS; Jang HJ; Shah R; Yoon D; Hamaji M; Wald O; Lee JS; Sugarbaker DJ; Burt BM
Clin Cancer Res; 2017 Aug; 23(16):4855-4864. PubMed ID: 28400429
[No Abstract] [Full Text] [Related]
14. Next-generation sequencing in thymic epithelial tumors uncovered novel genomic aberration sites and strong correlation between TMB and MSH6 single nucleotide variations.
Chen K; Che J; Zhang X; Jin R; Xiang J; Han D; Sun Y; Gong Z; Zhang D; Li H
Cancer Lett; 2020 Apr; 476():75-86. PubMed ID: 32061754
[TBL] [Abstract][Full Text] [Related]
15. Massively parallel sequencing identifies recurrent mutations in TP53 in thymic carcinoma associated with poor prognosis.
Moreira AL; Won HH; McMillan R; Huang J; Riely GJ; Ladanyi M; Berger MF
J Thorac Oncol; 2015 Feb; 10(2):373-80. PubMed ID: 25299233
[TBL] [Abstract][Full Text] [Related]
16. Elevated CRP levels predict poor outcome and tumor recurrence in patients with thymic epithelial tumors: A pro- and retrospective analysis.
Janik S; Bekos C; Hacker P; Raunegger T; Ghanim B; Einwallner E; Beer L; Klepetko W; Müllauer L; Ankersmit HJ; Moser B
Oncotarget; 2017 Jul; 8(29):47090-47102. PubMed ID: 28514756
[TBL] [Abstract][Full Text] [Related]
17. Genomic characterization of thymic epithelial tumors in a real-world dataset.
Kurokawa K; Shukuya T; Greenstein RA; Kaplan BG; Wakelee H; Ross JS; Miura K; Furuta K; Kato S; Suh J; Sivakumar S; Sokol ES; Carbone DP; Takahashi K
ESMO Open; 2023 Oct; 8(5):101627. PubMed ID: 37703595
[TBL] [Abstract][Full Text] [Related]
18. Diffuse high intensity PD-L1 staining in thymic epithelial tumors.
Padda SK; Riess JW; Schwartz EJ; Tian L; Kohrt HE; Neal JW; West RB; Wakelee HA
J Thorac Oncol; 2015 Mar; 10(3):500-8. PubMed ID: 25402569
[TBL] [Abstract][Full Text] [Related]
19. Molecular landscape of thymic epithelial tumors.
Prays J; Ortiz-Villalón C
Semin Diagn Pathol; 2022 Mar; 39(2):131-136. PubMed ID: 34272124
[TBL] [Abstract][Full Text] [Related]
20. PI3K as a Potential Therapeutic Target in Thymic Epithelial Tumors.
Alberobello AT; Wang Y; Beerkens FJ; Conforti F; McCutcheon JN; Rao G; Raffeld M; Liu J; Rahhal R; Zhang YW; Giaccone G
J Thorac Oncol; 2016 Aug; 11(8):1345-1356. PubMed ID: 27117832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
